bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.090
+0.830 (319.23%)
At close: Apr 1, 2025, 4:00 PM
1.310
+0.220 (20.16%)
After-hours: Apr 1, 2025, 7:59 PM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 75 employees as of December 31, 2023. The number of employees increased by 61 or 435.71% compared to the previous year.
Employees
75
Change (1Y)
61
Growth (1Y)
435.71%
Revenue / Employee
$124,827
Profits / Employee
-$120,531
Market Cap
16.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIAF News
- 1 day ago - bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - Business Wire
- 6 days ago - Case Study: bioAffinity Technologies' CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - Business Wire
- 13 days ago - Case Study: bioAffinity Technologies' Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - Business Wire
- 19 days ago - Physicians' Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer - Business Wire
- 26 days ago - bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth - Business Wire
- 4 weeks ago - WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million - PRNewsWire
- 4 weeks ago - bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million - Business Wire
- 5 weeks ago - WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million - PRNewsWire